Developing a rule for the antibiotics treatment of moderate pneumonia with fluoroquinolones or beta-lactams based on data of an observational study

Introduction: Selecting the appropriate antibiotics treatment against moderate pneumonia is still a matter of debate. To develop a treatment rule for the decision of a beta-lactam or a fluoroquinolone antibiotic, we develop machine learning (ML) methods based on scoring models, trained on ex ante available [for full text, please go to the a.m. URL]